Mostrar el registro sencillo del ítem

MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis

dc.contributor.authorFernández Ramos, D.
dc.contributor.authorFernández Tussy, P.
dc.contributor.authorLopitz Otsoa, F.
dc.contributor.authorFernández Fernández, Agustín 
dc.contributor.authorFernández Fraga, Mario 
dc.date.accessioned2019-01-30T07:57:48Z
dc.date.available2019-01-30T07:57:48Z
dc.date.issued2018
dc.identifier.citationCell Death and Disease, 9(10), p. 958- (2018); doi:10.1038/s41419-018-1014-y
dc.identifier.issn2041-4889
dc.identifier.urihttp://hdl.handle.net/10651/49859
dc.description.sponsorshipThis work was supported by grants from NIH (US Department of Health and Human services)-R01AT001576 (S.C.L., J.M.M., and M.L.M.-C.), Ministerio de Economía, Industria y Competitividad: SAF2017-87301-R (M.L.M.-C.), Gobierno Vasco-Departamento de Salud 2013111114 (to M.L.M.-C.), BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia BIO15/CA/016/ BD (M.L.M.-C.), ELKARTEK 2016, Departamento de Industria del Gobierno Vasco (to M.L.M.-C.), Asociación Española contra el Cáncer (to T.C.D, P.F.-T. and M.L.M.-C.), Mitotherapeutix (to M.L.M.-C.), Daniel Alagille award from EASL (to T.C.D), Fundación Científica de la Asociación Española Contra el Cancer (AECC Scientific Foundation) Rare Tumor Calls 2017 (to M.L.M, J.M.B., and M.A), La Caixa Foundation Program (to M.L.M, J.M.B.), FIS: PI15/00892 (to M.F.F), FIS: PI15/01132 and FIS PI18/01075 (to J.M.B.), (to J.M.B.), FIS: PI14/00399 and PI17/ 00022 (to M.J.P.), Miguel Servet Program (CON14/00129 to J.M.B.), Ramon y Cajal Program (RYC-2015-17755 to M.J.P.), GRUPIN14-052 (to M.F.), PI14/00962 Instituto Carlos III (to J.B.), AECC Scientific Foundation (to J.B.), World Wide Cancer Research (to J.B.), Programma di Ricerca Regione-Università 2007-2009 and 2011-2012, Regione Emilia-Romagna (to E.V.), “Diputación Foral Gipuzkoa” (DFG15/010, DFG16/004 to J.M.B.), BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia BIO15/CA/016/BD to J.M.B.), Department of Health of the Basque Country (2013111173 to J.M.B.; 2015111100 to M.J.P.). Ciberehd_ISCIII_MINECO is funded by the Instituto de Salud Carlos III. “Hepacare Project” from Fundación La Caixa, Spain (to M.A.A and C.B.), BiO-Eusko Fundazioa project BIO15/CA/011 (to M.A.A and C.B.). We thank this work produced with the support of a 2017 Leonardo Grant for Researchers and Cultural Creators, BBVA Foundation (to M.V.R.). We thank MINECO for the Severo Ochoa Excellence Accreditation (SEV-2016-0644).
dc.description.statementofresponsibilityFernández-Ramos, D., Fernández-Tussy, P., Lopitz-Otsoa, F., Gutiérrez-de-Juan, V., Navasa, N., Barbier-Torres, L., Zubiete-Franco, I., Simón, J., Fernández, A.F., Arbelaiz, A., Aransay, A.M., Lavín, J.L., Beraza, N., Perugorria, M.J., Banales, J.M., Villa, E., Fraga, M.F., Anguita, J., Avila, M.A., Berasain, C., Iruzibieta, P., Crespo, J., Lu, S.C., Varela-Rey, M., Mato, J.M., Delgado, T.C., Martínez-Chantar, M.L.
dc.format.extentp. 958-
dc.language.isoeng
dc.relation.ispartofCell Death and Disease, 9
dc.rights© 2018 Fernández Ramos et al.
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85053619096&doi=10.1038%2fs41419-018-1014-y&partnerID=40&md5=ca87572e7ea2edb26e9422948cf89b16
dc.titleMiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
dc.typejournal article
dc.identifier.doi10.1038/s41419-018-1014-y
dc.relation.projectIDMINECO/SAF2017-87301-R
dc.relation.projectIDFID/PI15/00892
dc.relation.projectIDRYC-2015-17755
dc.relation.projectIDGRUPIN14-052
dc.relation.publisherversionhttp://dx.doi.org/10.1038/s41419-018-1014-y
dc.rights.accessRightsopen access


Ficheros en el ítem

untranslated

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© 2018 Fernández Ramos et al.
Este ítem está sujeto a una licencia Creative Commons